We are developing three businesses—“Bio-Hybrid Implants,” “Hair Regeneration,” and “Artificial Skin”—based on the world's first and unique organ regeneration technology. Aiming to realize QOL-oriented medicine supported by solid scientific evidence, we are committed to returning our research results to society, while contributing to the creation of new industries and the advancement of sustainable healthcare.